Active-duty service members and those seeking to enter military service face specific regulatory considerations around TRT that civilian patients don't encounter. The intersection of medical readiness requirements, aeromedical certification, and controlled substance policies creates a complex landscape.
Active-Duty Policies
TRT is not automatically disqualifying for continued military service. Service members can be prescribed testosterone through military healthcare (TRICARE) for documented hypogonadism. However, several considerations apply:
- Deployment readiness: Controlled substance prescriptions must be evaluated for deployment suitability. Injectable testosterone requiring cold-chain storage and injection supplies may affect deployment readiness determinations in austere environments.
- Medical Readiness Classification: TRT may result in a Medical Readiness Classification change depending on the underlying diagnosis and branch-specific policies.
- Drug testing: Military drug testing panels do not routinely screen for testosterone (it's endogenous). However, testosterone/epitestosterone (T/E) ratios can be evaluated if use is suspected.
Aeromedical Considerations
Flight status — for pilots, aircrew, and air traffic controllers — adds additional requirements:
Flight Status and TRT
- TRT typically requires an aeromedical waiver from the branch flight surgeon
- A stabilization period (usually 3–6 months) on TRT before waiver consideration
- Documented stable labs within physiological range
- No adverse effects (polycythemia, sleep apnea exacerbation) that would impair duty performance
- Waiver approval rates vary by branch and are case-specific
Accession (Joining the Military)
Current TRT use is generally disqualifying for military accession (initial entry). The rationale: the military requires that new members not be dependent on ongoing medication management for fitness. Waivers are theoretically possible but rarely granted for TRT at initial accession. Men considering military service may need to discontinue TRT and demonstrate adequate endogenous testosterone production to meet entry medical standards.
The Bottom Line
Regulated but Not Prohibited
Active-duty service members can receive TRT through military healthcare for documented hypogonadism. The practical considerations — deployment readiness, aeromedical waivers, and supply logistics — add complexity beyond civilian TRT management. Service members should work with their military healthcare provider and unit medical authority to navigate branch-specific policies. Those considering military entry should address TRT discontinuation before beginning the accession process.